PREVENT Trial
Cross-source consensus on PREVENT Trial from 1 sources and 4 claims.
1 sources · 4 claims
Background
Other
Highlighted claims
- The PREVENT trial is a randomized, sham-controlled, participant- and assessor-blinded, multicentre superiority trial. — Randomised, sham-controlled, double-blinded, multicentre international trial to evaluate the efficacy of the Ventfree Respiratory Muscle Stimulator to assist ventilator weaning in critically ill patients: a study protocol of a randomised controlled trial
- The trial is planned across up to 30 ICUs in the USA, France, the Netherlands, and Australia. — Randomised, sham-controlled, double-blinded, multicentre international trial to evaluate the efficacy of the Ventfree Respiratory Muscle Stimulator to assist ventilator weaning in critically ill patients: a study protocol of a randomised controlled trial
- Recruitment was completed in January 2026 after the first participant was enrolled on 15 February 2024. — Randomised, sham-controlled, double-blinded, multicentre international trial to evaluate the efficacy of the Ventfree Respiratory Muscle Stimulator to assist ventilator weaning in critically ill patients: a study protocol of a randomised controlled trial
- Participants are randomized 1:1 to active or sham treatment with stratification by country. — Randomised, sham-controlled, double-blinded, multicentre international trial to evaluate the efficacy of the Ventfree Respiratory Muscle Stimulator to assist ventilator weaning in critically ill patients: a study protocol of a randomised controlled trial